The rise of MAHA snacks, from protein-infused Pop-Tarts to avocado-oil chips, suggests a shift towards healthier eating. However, nutrition experts caution that the benefits may be overstated.
Thomas Goetz emphasizes that each drug represents a broader narrative involving health, medicine, society, and economics.
The CDC’s Epidemic Intelligence Service has reached a significant milestone, having trained over 4,300 individuals who are now integral to public health efforts.
Roche is advancing its experimental multiple sclerosis drug to regulators following successful trials, though significant safety concerns persist.
A recent study has mapped 55,000 genes in roses, which are vital ornamental plants. This research could significantly influence breeding practices, as currently, less than 10% of rose species are utilized.
In a notable move, key Republican senators are likely to oppose President Trump's proposed cuts to the National Institutes of Health and the reorganization of Health and Human Services for the second consecutive year.
As the leading donor in global health, the U.S. government allocates its budget across several critical program areas, including HIV, tuberculosis, and malaria.
A judge is anticipated to impose a $225 million forfeiture on Purdue Pharma, the maker of OxyContin, facilitating the completion of its settlement with the Justice Department.
A U.S. judge is anticipated to order Purdue Pharma to forfeit $225 million, marking a significant step in ongoing legal proceedings.
Recent developments indicate that a CDC conference, previously open to the public, may now have restricted access. This follows a federal ruling related to gender declaration and highlights ongoing issues in health policy.
KFF is set to debut a podcast hosted by Chip Kahn, focusing on the intricate relationship between health policy and business. The initiative aims to deepen understanding of these complexities.
The current U.S. health care system appears to prioritize retrospective evaluations, questioning the justification of past medical decisions.
This analysis explores the Executive Actions from the Trump administration that may affect the health of LGBTQ+ individuals, detailing their potential implications.
Research from Adelaide University indicates that daily probiotic supplementation could improve gut and skin health in dogs, potentially reducing skin infections.
Recent advancements in protein engineering may improve cancer therapies. Proteases, enzymes that act as molecular scissors, are crucial in developing treatments that target both viral replication and cancer cell destruction.
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
Recent developments highlight significant progress in targeting KRAS, a key player in cancer treatment, alongside other notable biotech news including the Breakthrough Prize winners.
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Recent discussions highlight the effects of cannabis on adolescent brain development, alongside updates on the CDC director nominee and a measles outbreak.
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.